Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection (Q44050760)

29 November 2017

Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection (English)

1 reference

29 November 2017

0 references

Vera Junker

1

1 reference

29 November 2017

Andreas Becker

2

1 reference

29 November 2017

Ricarda Hühne

3

1 reference

29 November 2017

Marat Zembatov

4

1 reference

29 November 2017

Alexander Ravati

5

1 reference

29 November 2017

Carsten Culmsee

6

1 reference

29 November 2017

Josef Krieglstein

7

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

European Journal of Pharmacology

29 November 2017

1 reference

29 November 2017

446

1 reference

29 November 2017

1-3

1 reference

29 November 2017

25-36

1 reference

A mouse model of focal cerebral ischemia for screening neuroprotective drug effects.

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: evidence for L-deprenyl-induced activation of reactive astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

The potential for treating neurodegenerative disorders with NGF-inducing compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

beta-adrenergic receptor-induced activation of nerve growth factor gene transcription in rat cerebral cortex involves CCAAT/enhancer-binding protein delta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Induction of nerve growth factor and basic fibroblast growth factor mRNA following clenbuterol: contrasting anatomical and cellular localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Beta-adrenergic receptors regulate astrogliosis and cell proliferation in the central nervous system in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Receptors for neurotransmitters on astrocytes in the mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

In vitro glial responses to nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

The pharmacology of salmeterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Evidence that the hypertrophic action of clenbuterol on denervated rat muscle is not propranolol-sensitive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Effect of hypoglycemia on changes of brain lactic acid and intracellular pH produced by ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by β-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cere

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Trophic factor production by reactive astrocytes in injured brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

NGF increases brain astrocyte number in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Clenbuterol, a beta(2)-adrenoceptor agonist, improves locomotor and histological outcomes after spinal cord contusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

Stimulation of beta2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

The beta2-adrenoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901814-9

10.1016/S0014-2999(02)01814-9

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference